# Sumatriptan Succinate

NDC: 63323-273
Generic name: Sumatriptan Succinate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20110412

FDA application: ANDA079242

## Active ingredients

- SUMATRIPTAN SUCCINATE: 6 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-273"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-273
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b183c7ba-2cc6-4854-a9a6-71ccd3592586